About Protein FAM83E
Protein FAM83E (FAM83E) is a protein
from Homo sapiens identified by UniProt accession
Q2M2I3, 478 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Protein FAM83E |
| UniProt accession | Q2M2I3 |
| Gene | FAM83E |
| Organism | Homo sapiens |
| Length | 478 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- sphingomyelin measurement · score 0.32
- alkaline phosphatase measurement · score 0.28
- neutrophil count · score 0.28
- lymphocyte count · score 0.26
- leukocyte count · score 0.24
- myeloid white cell count · score 0.22
- Red cell distribution width · score 0.22
- neutrophil-to-lymphocyte ratio · score 0.21
- lymphocyte percentage of leukocytes · score 0.17
- neutrophil percentage of leukocytes · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q2M2I3-F1 | alphafold | PREDICTED | 69.56 | — |
Amino-acid sequence (478 residues)
MAASQLAALE GVDSGPRVPG ASPGFLYSEG QRLALEALLS KGAEAFQTCV QREELWPFLS ADEVQGLAAA AEDWTVAKQE PSGMAEGATT TDVDAGSLSY WPGQSEQPAP VLRLGWPVDS AWKGITRAQL YTQPPGEGQP PLKELVRLEI QAAHKLVAVV MDVFTDPDLL LDLVDAATRR WVPVYLLLDR QQLPAFLELA QQLGVNPWNT ENVDVRVVRG CSFQSRWRRQ VSGTVREKFV LLDGERVISG SYSFTWSDAR LHRGLVTLLT GEIVDAFSLE FRTLYAASCP LPPAPPQKPS VIGGLQRGRS PHRVSRRRSV APASPPPPDG PLAHRLAACR VSPATPGPAL SDILRSVQRA RTPSGPPARP SRSMWDLSRL SQLSGSSDGD NELKKSWGSK DTPAKALMRQ RGTGGGPWGE VDSRPPWGGA LPLPPAHRLR YLSPARRRFG GDATFKLQEP RGVRPSDWAP RAGLGGQP
Explore Protein FAM83E with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets